title: Matrine inhibits the expression of adhesion molecules in activated vascular smooth muscle cells.
abstract: Atherosclerosis is a chronic inflammatory disease associated with increased expression of adhesion molecules in vascular smooth muscle cells (VSMCs). Matrine is a main active ingredient of Sophora flavescens roots, which are used to treat inflammatory diseases. However, the effects of matrine on the expression of adhesion molecules in VSMCs have largely remained elusive. Therefore, the present study investigated the effects of matrine on the expression of adhesion molecules in tumor necrosis factor (TNF)‑α‑stimulated human aortic smooth muscle cells (HASMCs). The results showed that matrine inhibited the expression of vascular cell adhesion molecule‑1 (VCAM‑1) and intercellular adhesion molecule‑1 (ICAM‑1) in TNF‑α‑stimulated HASMCs. Matrine markedly inhibited the TNF‑α‑induced expression of nuclear factor (NF)‑κB p65 and prevented the TNF‑α‑caused degradation of inhibitor of NF‑κB; it also inhibited TNF‑α‑induced activation of mitogen‑activated protein kinases (MAPKs). Furthermore, matrine inhibited the production of intracellular reactive oxygen species (ROS) in TNF‑α‑stimulated HASMCs. In conclusion, the results of the present study demonstrated that matrine inhibited the expression of VCAM‑1 and ICAM‑1 in TNF‑α‑stimulated HASMCs via the suppression of ROS production as well as NF‑κB and MAPK pathway activation. Therefore, matrine may have a potential therapeutic use for preventing the advancement of atherosclerotic lesions.
authors.affiliation: Department of Geriatrics, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi 710038, P.R. China.
authors.forename: Jun
authors.initials: J
authors.lastname: Liu
authors.affiliation: Department of Geriatrics, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi 710038, P.R. China.
authors.forename: Lihua
authors.initials: L
authors.lastname: Zhang
authors.affiliation: Department of Geriatrics, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi 710038, P.R. China.
authors.forename: Yingang
authors.initials: Y
authors.lastname: Ren
authors.affiliation: Department of Geriatrics, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi 710038, P.R. China.
authors.forename: Yanli
authors.initials: Y
authors.lastname: Gao
authors.affiliation: Department of Geriatrics, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi 710038, P.R. China.
authors.forename: Li
authors.initials: L
authors.lastname: Kang
authors.affiliation: Department of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi 710038, P.R. China.
authors.forename: Shaoping
authors.initials: S
authors.lastname: Lu
mesh_terms: D000470:Alkaloids / Q000494:pharmacology*; D015815:Cell Adhesion Molecules / Q000378:metabolism*; D002470:Cell Survival / Q000187:drug effects; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000166:cytology*; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000378:metabolism*; D000072000:NF-KappaB Inhibitor alpha / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D059748:Proteolysis / Q000187:drug effects; D011807:Quinolizines / Q000494:pharmacology*; D017382:Reactive Oxygen Species / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D000093842:Matrines
chemical_list: D000470:Alkaloids; D015815:Cell Adhesion Molecules; D016328:NF-kappa B; D011807:Quinolizines; D017382:Reactive Oxygen Species; D014409:Tumor Necrosis Factor-alpha; D000072000:NF-KappaB Inhibitor alpha; D020928:Mitogen-Activated Protein Kinases; D000093842:Matrines